Legal & General Group PLC Aveo Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.48 - $14.97 $69,976 - $123,532	8,252 New	8,252 $123,000
Q2 2021 Aug 12, 2021	SELL	$6.21 - $7.45 $13,308 - $15,965	-2,143 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.97 - $15.28 $1,116 - $2,857	-187 Reduced 8.03%	2,143 $16,000
Q3 2020 Nov 13, 2020	BUY	$4.16 - $6.26 $1,297 - $1,953	312 Added 15.46%	2,330 $14,000
Q2 2020 Aug 14, 2020	BUY	$3.47 - $9.99 $7,002 - $20,159	2,018 New	2,018 $10,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.